2m 2m 2m 2m 2m 2m 2m
Regeneron Pharma (REGN)
NASDAQ
$783.40+$1.91 (+0.24%)
Price as of Sep 11, 2026 7:36 PM EDT- $79.0BMarket Cap
- 40.27%1-Year Change
- BiotechnologyIndustry
Regeneron Pharma (REGN)
$783.40+$1.91 (+0.24%)
REGN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $781.49 | ||
Change | -$11.77 (-1.48%) | ||
Open | $800.00 | ||
High | $800.22 | ||
Low | $780.81 | ||
Previous Close | $793.26 | ||
Volume | 443,989 | ||
30-Day Average Volume | 623,155 | ||
1-Week Change | -5.59% | ||
1-Month Change | -1.83% | ||
1-Year Change | 40.27% | ||
3-Year Change | -5.36% | ||
5-Year Change | 21.27% | ||
Fundamentals | |||
Shares Outstanding | 101.1M | ||
Total Assets | $41.7B | ||
Market Cap | $79.0B | ||
Enterprise Value | $78.6B | ||
Period: QTR TTM FY | |||
Revenue | $1.6B | ||
Net Income | $1.3B | ||
Free Cash Flow | $572.8M | ||
EBIT | $1.5B | ||
EBITDA | $1.7B | ||
Net Working Capital | $12.9B | ||
EPS | $12.23 | ||
Enterprise Value/EBITDA | 48 | ||
Enterprise Value/Revenue | 48 | ||
P/B | 2 | ||
P/E | 64 | ||
PEG | 1 | ||
Price/Free Cash Flow | 138 | ||
Price/Operating Cash Flow | 97 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | 0.48% | ||
Trailing Annual Dividend Yield | 0.47% | ||
Ex-Dividend Date | 08/18/2026 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue
Annual Dividend Yield